JP2023509422A5 - - Google Patents
Info
- Publication number
- JP2023509422A5 JP2023509422A5 JP2022540328A JP2022540328A JP2023509422A5 JP 2023509422 A5 JP2023509422 A5 JP 2023509422A5 JP 2022540328 A JP2022540328 A JP 2022540328A JP 2022540328 A JP2022540328 A JP 2022540328A JP 2023509422 A5 JP2023509422 A5 JP 2023509422A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962955839P | 2019-12-31 | 2019-12-31 | |
| US62/955,839 | 2019-12-31 | ||
| US202063090538P | 2020-10-12 | 2020-10-12 | |
| US63/090,538 | 2020-10-12 | ||
| PCT/US2020/067483 WO2021138434A1 (en) | 2019-12-31 | 2020-12-30 | Compounds and compositions for treating conditions associated with sting activity |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023509422A JP2023509422A (ja) | 2023-03-08 |
| JP2023509422A5 true JP2023509422A5 (https=) | 2024-01-11 |
| JPWO2021138434A5 JPWO2021138434A5 (https=) | 2024-01-11 |
| JP7756643B2 JP7756643B2 (ja) | 2025-10-20 |
Family
ID=74206237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540328A Active JP7756643B2 (ja) | 2019-12-31 | 2020-12-30 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230127839A1 (https=) |
| EP (1) | EP4085051A1 (https=) |
| JP (1) | JP7756643B2 (https=) |
| CN (2) | CN120965654A (https=) |
| PY (1) | PY2089159A (https=) |
| TW (1) | TW202136239A (https=) |
| UY (1) | UY39006A (https=) |
| WO (1) | WO2021138434A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112823036B (zh) | 2018-07-03 | 2024-11-08 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| EP4267129A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| WO2022140397A1 (en) | 2020-12-22 | 2022-06-30 | Ifm Due, Inc. | Methods of treating cancer |
| US20240060982A1 (en) | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
| EP4267128A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| TW202235073A (zh) | 2021-01-08 | 2022-09-16 | 美商Ｉｆｍ Ｄｕｅ有限公司 | 用於治療與sting活性相關的病狀之化合物及組合物 |
| JP2024502470A (ja) * | 2021-01-08 | 2024-01-19 | アイエフエム デュー インコーポレイテッド | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
| CN116981668A (zh) * | 2021-04-09 | 2023-10-31 | 百济神州(北京)生物科技有限公司 | 制备bcl-2抑制剂的中间体的方法 |
| UY39892A (es) | 2021-08-10 | 2023-03-31 | Novartis Pharma Ag | Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| CN117756698A (zh) * | 2022-12-16 | 2024-03-26 | 中国药科大学 | 脲类化合物及其作为sting抑制剂的医药用途 |
| CN116023321B (zh) * | 2022-12-30 | 2024-11-29 | 中国药科大学 | Sting抑制剂前药及其医药用途 |
| CN120794982A (zh) * | 2024-05-14 | 2025-10-17 | 中国药科大学 | 吡唑类sting抑制剂及其医药用途 |
| CN120794957A (zh) * | 2024-05-14 | 2025-10-17 | 中国药科大学 | 苯并含氮杂环类sting抑制剂及其医药用途 |
| WO2026023667A1 (ja) * | 2024-07-25 | 2026-01-29 | カルナバイオサイエンス株式会社 | フェニルピペラジン誘導体 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5783558A (en) * | 1980-11-13 | 1982-05-25 | Asahi Chem Ind Co Ltd | Novel organic compound and its preparation |
| JPS5783557A (en) * | 1980-11-14 | 1982-05-25 | Asahi Chem Ind Co Ltd | Novel azomethine compound and its preparation |
| US20120046290A1 (en) * | 1997-12-22 | 2012-02-23 | Jacques Dumas | Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| WO2003028720A1 (en) * | 2001-09-26 | 2003-04-10 | Pharmacia Italia S.P.A. | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| US8188113B2 (en) * | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| WO2012062462A1 (en) * | 2010-11-10 | 2012-05-18 | Grünenthal GmbH | Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| WO2012075380A1 (en) | 2010-12-03 | 2012-06-07 | The Trustees Of The University Of Pennsylvania | Tip60 inhibitors |
| CN102516153B (zh) * | 2011-12-14 | 2014-03-12 | 南京工业大学 | 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用 |
| CA2914815A1 (en) * | 2013-06-11 | 2014-12-18 | Kala Pharmaceuticals, Inc. | Urea derivatives and uses thereof |
| CN109394752A (zh) | 2013-10-21 | 2019-03-01 | 德雷克塞尔大学 | 治疗慢性乙型肝炎病毒感染的sting激动剂的用途 |
| CN107417478B (zh) * | 2017-06-05 | 2020-05-05 | 南京师范大学 | 一种催化氧化羰基化合成不对称二取代脲的方法 |
| EP3556362A1 (en) * | 2018-04-16 | 2019-10-23 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sting inhibitors |
| WO2020191227A1 (en) * | 2019-03-20 | 2020-09-24 | Cornell University | Methods for controlling prostaglandin-mediated biological processes |
| EP4267128A1 (en) * | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| EP4267129A1 (en) * | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| WO2022140397A1 (en) * | 2020-12-22 | 2022-06-30 | Ifm Due, Inc. | Methods of treating cancer |
| US20240060982A1 (en) * | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
-
2020
- 2020-12-30 JP JP2022540328A patent/JP7756643B2/ja active Active
- 2020-12-30 CN CN202511145327.2A patent/CN120965654A/zh active Pending
- 2020-12-30 PY PY202002089159A patent/PY2089159A/es unknown
- 2020-12-30 UY UY0001039006A patent/UY39006A/es unknown
- 2020-12-30 US US17/789,694 patent/US20230127839A1/en active Pending
- 2020-12-30 TW TW109146905A patent/TW202136239A/zh unknown
- 2020-12-30 CN CN202080097901.0A patent/CN115348957B/zh active Active
- 2020-12-30 WO PCT/US2020/067483 patent/WO2021138434A1/en not_active Ceased
- 2020-12-30 EP EP20845545.1A patent/EP4085051A1/en active Pending